SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-068979
Filing Date
2023-08-18
Accepted
2023-08-18 16:30:14
Documents
13
Period of Report
2023-08-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea183877-8k_aditxt.htm   iXBRL 8-K 24972
2 SHAREHOLDER UPDATE DATED AUGUST 18, 2023 ea183877ex99-1_aditxt.htm EX-99.1 30249
  Complete submission text file 0001213900-23-068979.txt   235752

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20230818.xsd EX-101.SCH 3009
4 XBRL LABEL FILE adtx-20230818_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20230818_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT ea183877-8k_aditxt_htm.xml XML 3301
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 231186208
SIC: 2834 Pharmaceutical Preparations